Diabetes drugs may benefit all people with heart failure
There are more than 64 million people worldwide affected by heart failure, half of whom have mildly reduced or preserved ejection fraction.
In a study from Brigham...
Common diabetes drug can slow kidney function decline, study finds
In a study from University Medical Center Groningen, scientists found that dapagliflozin— a sodium-glucose cotransporter 2 inhibitor prescribed to treat diabetes—reduces the rate of...
This insulin drug may benefit people with type 2 diabetes, study finds
In a study from the University at Buffalo, scientists found that an insulin-sensitizing drug can benefit patients with insulin resistance at lower doses than...
Diabetes and cholesterol drugs may lower vision loss risk in older people
Age-related macular degeneration (AMD) is the leading cause of severe visual impairment among older people in high-income countries.
In a study from the University of...
Widely used diabetes drug could help you lose weight regardless of age
Weight loss is often accompanied by loss of lean body mass, which can negatively impact physical functioning and/or resting energy expenditure.
Bodyweight loss and body...
People with diabetes on Medicare Advantage plans more likely to have worse health
Diabetes is reported in 1 in 5 Medicare beneficiaries age 65 and older and is associated with over 60% higher out-of-pocket prescription costs compared...
A better way to treat obesity and diabetes
Obesity is the main cause of type 2 diabetes and related chronic illnesses that together will kill more people around the globe this year...
Drug combo for type 2 diabetes remains effective after 2 years
People with Type 2 diabetes often take metformin as first-line therapy to help stabilize their blood glucose.
Eventually, some patients no longer respond to metformin...
Vitamin D and estrogen may help prevent heart disease, stroke, diabetes
Vitamin D and estrogen have already shown well-documented results in improving bone health in women.
Common diabetes drug may increase heart failure risk
Rosiglitazone belongs to a class of drugs called thiazolidinediones, a new class of drugs for the treatment of type 2 diabetes.
In a recent study...